Updated – Johnson & Johnson Plans to Appeal $1 Billion on Defective Hip Implant
A federal jury in Dallas ruled Thursday that pharmaceutical and medical device maker Johnson & Johnson and one of its subsidiaries is guilty of “despicable and vile conduct” for knowingly and fraudulently selling metal-on-metal hip implants that they knew were seriously defective.








